YOLFTbeta
Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B · ST · Healthcare / Medical Devices

1.70SEK-0.05 (-2.75%)

Price History

Full chart

Market Stats

Previous Close1.75
Open1.79
Day Range1.59 – 1.79
52-Week Range1.70 – 10.48
Volume158.87K
Market Cap85.10M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.30
Dividend Yield0.00%
Beta-0.09
50-Day Avg1.87
200-Day Avg4.34

About

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Dan Johansson Mogren
  • Employees13
  • HeadquartersBuilding 405, Lund, Sweden, 223 81, Sweden
  • Websitehttps://www.clinicallaser.se

Leadership

  • Mr. Dan Johansson MogrenChief Executive Officer · b. 1964
  • Prof. Katarina LundqvistChief Financial Officer · b. 1972
  • Mr. Jimmy JohanssonChief Operating Officer · b. 1981
  • Ms. Cristina PantaleoneChief Technical Officer · b. 1987
  • Verena KnappeC.P.O

Financials

Income Statement

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue150.00K200.00K350.48K350.00K123.14K12.00K--3.64M614.45K1.81M1.43M1.33M2.25M6.27M8.27M18.78M17.49M
Growth (%)-+33.33%+75.24%-0.14%-64.82%-90.25%----83.11%+194.25%-21.13%-6.59%+68.54%+179.20%+31.99%+127.04%-6.90%
Cost of Revenue----11.39M--53.34K53.34K-3.04M1.30M1.01M456.00K5.88M9.06M5.28M8.36M46.48M
Gross Profit150.00K200.00K350.48K350.00K-11.39M---53.34K3.58M3.65M509.00K416.00K876.00K-3.63M-2.79M3.00M10.42M-29.00M
Gross Margin100.00%100.00%100.00%100.00%-9253.18%---98.54%594.03%28.15%29.17%65.77%-161.69%-44.51%36.23%55.47%-165.81%
Operating Expense767.00K2.11M5.29M7.38M1.35M--16.55M30.48M24.53M33.96M42.77M52.97M57.05M64.65M68.93M64.67M0
Operating Income-617.00K-1.91M-4.94M-7.03M-12.75M-18.15M-17.91M-16.60M-26.90M-20.88M-33.45M-42.36M-52.10M-60.68M-67.44M-65.93M-54.25M-29.00M
Operating Margin-411.33%-956.01%-1410.34%-2007.73%-10351.16%-151233.33%---739.59%-3398.17%-1850.17%-2970.48%-3911.11%-2702.98%-1075.97%-796.97%-288.85%-165.81%
EBITDA-569.00K-1.85M-4.86M-6.94M-12.56M-18.03M-17.74M-16.54M-26.89M-21.02M-32.55M-39.42M-51.61M-57.05M-57.84M-68.41M-44.76M-26.41M
EBITDA Margin-379.33%-926.51%-1385.51%-1982.87%-10201.73%-150225.00%---739.48%-3421.44%-1800.44%-2764.31%-3874.77%-2541.31%-922.83%-826.86%-238.28%-151.03%
Net Income-671.00K-1.98M-4.97M-6.97M-12.70M-18.32M-17.84M-16.59M-26.95M-21.26M-32.85M-43.38M-57.94M-63.62M-70.66M-79.79M-47.62M-41.61M
Net Income Margin-447.33%-988.51%-1418.90%-1992.87%-10311.36%-152708.33%---740.97%-3460.50%-1817.20%-3041.73%-4349.77%-2833.63%-1127.31%-964.49%-253.54%-237.96%
R&D-------1.90M1.54M1.72M2.02M2.38M2.38M2.10M2.13M2.13M--
R&D as % of Total Revenue--------42.37%279.60%111.45%166.62%178.38%93.72%33.98%25.75%--
Interest Expense60.00K64.79K45.96K015.72K182.06K41.98K94536364.84K97.88K1.27M3.27M6.41M10.97M9.76M433.00K93.97K
Interest Expense % of Total Revenue40.00%32.40%13.11%0.00%12.77%1517.21%--0.01%10.55%5.41%89.41%245.57%285.30%175.05%117.97%2.31%0.54%

Balance Sheet

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.52M8.20M11.76M13.01M20.06M29.20M36.95M22.27M27.30M44.94M58.02M38.67M44.40M66.74M49.51M57.73M78.56M76.49M
Total Liabilities1.85M1.57M1.41M2.17M2.97M3.11M5.38M2.81M10.24M11.94M8.21M31.67M30.47M45.55M41.64M14.20M12.88M10.00M
Total Equity3.68M6.63M10.36M10.83M17.09M26.09M31.58M19.46M17.06M33.00M49.81M7.00M13.93M21.79M9.22M45.77M68.72M69.67M
Cash1.99M1.26M2.91M2.37M7.05M13.50M18.70M2.63M6.20M2.02M474.10K2.16M594.67K1.71M10.45M15.33M22.51M21.55M
Total Debt12.54K160.00K333.33K280.17K106.83K73.50K73.50K73.50K73.50K1.87M1.47M1.07M673.50K273.50K30.68M454.00K224.00K-
Net Debt-1.98M-1.10M-2.58M-2.09M-6.95M-13.43M-18.63M-2.56M-6.12M-145.35K999.40K-1.08M78.83K-1.43M20.23M-14.88M-22.28M-21.55M

Cash Flow

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-69.30K-2.28M-4.92M-5.96M-12.05M-18.30M-15.74M-18.68M-19.63M-24.39M-38.72M-39.12M-55.41M-66.17M-70.69M-66.45M-56.45M-33.20M
Investing Cash Flow-2.01M-3.32M-1.90M-1.79M-2.06M-2.45M-2.41M-1.90M-1.54M-4.67M-2.38M-40.00K-508.00K-408.00K-886.00K-5.50M-7.47M-2.80M
Financing Cash Flow3.81M4.87M8.47M7.21M18.79M27.29M23.36M4.50M24.74M38.56M49.87M20.33M62.02M85.88M61.84M76.69M71.10M35.04M
Capital Expenditure2.01M3.32M1.90M1.79M2.06M2.45M2.41M1.90M1.54M4.67M2.38M348.00K348.00K555.00K562.00K5.50M2.46M2.80M
Free Cash Flow-2.08M-5.60M-6.82M-7.75M-14.11M-20.75M-18.16M-20.57M-21.17M-29.06M-41.10M-39.12M-55.76M-66.73M-71.25M-71.95M-58.92M-36.00M
FCF to OCF3003.20%245.63%138.73%130.03%117.09%113.36%115.34%110.16%107.85%119.16%106.14%100.00%100.63%100.84%100.80%108.27%104.36%108.43%

Earnings

Report DateDec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Aug 20, 2015Sep 30, 2015Dec 31, 2015May 26, 2016Jun 30, 2016Sep 30, 2016Jan 31, 2017May 18, 2017Aug 24, 2017Nov 16, 2017Feb 22, 2018May 9, 2018Aug 23, 2018Nov 22, 2018Feb 14, 2019May 16, 2019Aug 22, 2019Nov 21, 2019Feb 28, 2020May 28, 2020Aug 26, 2020Nov 19, 2020Feb 26, 2021May 31, 2021Aug 24, 2021Nov 18, 2021Feb 24, 2022May 19, 2022Aug 11, 2022Nov 17, 2022Feb 23, 2023May 25, 2023Aug 25, 2023Nov 17, 2023Feb 23, 2024May 29, 2024Aug 23, 2024Oct 31, 2024Feb 21, 2025May 16, 2025Aug 15, 2025Nov 14, 2025Feb 21, 2026May 14, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------
EPS Actual-10.43-10.06-12.01-10.98-16.98-6.53-8.77-7.83-21.83-9.97-0.13-8.11-9.74-0.25-11.64-14.67-0.14-0.21-0.15-0.10-0.11-0.03-0.34-0.16-0.21-0.21-0.23-0.18-0.33-0.40-0.22-0.16-0.23-0.17-0.35-0.15-0.24-0.17-0.20-0.42-0.05-0.15-0.10-0.04-0.02-1.70-0.01-0.98-0.43-0.71-0.25-0.32-0.39-0.24-0.38
Surprise-------------------------------------------------------
Timing----------Pre-market--Pre-market--Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap85.10M
Enterprise Value66.27M
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.78
Price / Book1.84
EPS-1.30
Book Value1.54
Revenue (TTM)12.56M
Gross Profit (TTM)6.98M
EBITDA-32.25M
Profit Margin0.00%
Operating Margin-91.44%
Return on Equity-73.31%
Return on Assets-31.46%
Shares Outstanding48.52M
Shares Float25.47M
Beta-0.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 30, 2026195:193
  • Jun 7, 2024737:710
  • Apr 25, 20241:200
  • Jun 14, 20231148:373
  • Aug 17, 2022162:131
  • Apr 8, 2021533:515
  • Jan 14, 2020355:342
  • May 22, 20181753:1735
  • Jan 26, 20171023:986
  • Jan 19, 2016691:678
  • Oct 29, 2014824:811
  • Oct 2, 2013714:667
  • May 2, 20121148:1129
  • Jan 18, 2012825:811
  • Jan 20, 20101234:1213